Independent and not affiliated with the FDA, MHRA, ISPE, PDA, or any agency. Get the appgoutham@madhadi.com
madhadi.comData Integrity & GxP Quality
Browse all topics → Articles Templates & Procedures Learning paths GlossaryScenariosToolsRegulatory ReferencesLearning PathsTopics About Start here
Template Plug-and-play starting point Quality Assurance

Worksheet: LRV and Viral Clearance Summary Calculation

A plug-and-play worksheet to calculate log reduction values (LRV) from viral spiking study data, sum orthogonal steps into a cumulative process clearance, and document the safety margin against the estimated viral burden, with a filled specimen.

Document type: Template

Read and copy the template below into your own quality system. It is a generic starting point for your own internal use, provided as is, with no warranty; see the Terms and License. Adopting it does not by itself create compliance.

This is a ready-to-use calculation worksheet for viral clearance data generated under a spiking study protocol. It is a calculation aid, not a validated tool; if you build it into a spreadsheet used for GxP decisions, validate that spreadsheet per your infrastructure qualification program. Replace every <<FILL: ...>> placeholder with your own values. A worked filled specimen follows. Confirm every input and threshold against your approved study protocol.

Section 1: per-step LRV calculation

For each spiked step, LRV is calculated from total virus (titer multiplied by volume), not titer alone.

FieldLoad (pre-step)Product pool (post-step)
Infectious titer (log10 TCID50/mL or PFU/mL)<<FILL>><<FILL>>
Volume (mL)<<FILL>><<FILL>>
Total virus (log10 titer + log10 volume)<<FILL: A>><<FILL: B>>
LRV = A minus B<<FILL>>

If the post-step result is below the assay’s limit of detection, report the LRV as a “greater than” value bounded by the limit of detection and the sample volume assayed, not as an absolute number: <<FILL: e.g. LRV greater than 5.3, limited by 10 mL assayed at LOD 1.5 log10>>.

Section 2: inactivation kinetics (for time-dependent steps, e.g. low-pH hold)

Time point (min)Infectious titer (log10)LRV from t=0
0<<FILL>>0.0
<<FILL>><<FILL>><<FILL>>
<<FILL>><<FILL>><<FILL>>
Process hold time<<FILL>><<FILL>>

Confirm the kill curve reaches a plateau (essentially complete inactivation) before the process hold time. A single endpoint with no intermediate time points does not demonstrate kinetics.

Section 3: orthogonality check before summing

StepMechanismOrthogonal to which other step(s)?Include in cumulative sum?
<<FILL>><<FILL: inactivation / size-exclusion removal / charge-based removal>><<FILL>><<FILL: Yes/No + rationale>>
<<FILL>><<FILL>><<FILL>><<FILL>>
<<FILL>><<FILL>><<FILL>><<FILL>>

Only steps with genuinely different clearance mechanisms may be summed independently. Two steps sharing the same mechanism are not both counted at full value without documented justification.

Section 4: cumulative process clearance per virus

VirusStep 1 LRVStep 2 LRVStep 3 LRVCumulative LRV
<<FILL>><<FILL>><<FILL>><<FILL>><<FILL: sum>>
<<FILL>><<FILL>><<FILL>><<FILL>><<FILL>>

Section 5: safety margin statement

InputValue
Estimated viral burden of unprocessed bulk (e.g., retrovirus-like particles by TEM, particles/L or particles/dose)<<FILL>>
Cumulative process LRV for the relevant virus<<FILL>>
Estimated particles remaining after clearance (burden minus 10^LRV)<<FILL>>
Safety margin statement<<FILL: e.g. "cumulative clearance exceeds the estimated load by more than N log10">>

Section 6: sign-off

RoleNameSignatureDate
Calculated by<<FILL>>
Reviewed by (Validation)<<FILL>>
Approved by (QA)<<FILL>>

Filled specimen

Illustrative low-pH inactivation step for X-MuLV. Numbers are illustrative.

Section 1:

FieldLoadProduct pool
Infectious titer (log10 TCID50/mL)6.8less than 1.5 (below detection)
Volume (mL)500480
Total virus (log10)9.5less than 4.2
LRVgreater than 5.3

Section 2 (kinetics):

Time (min)Titer (log10)LRV from t=0
06.80.0
153.13.7
30less than 1.5greater than 5.3
60 (process hold)less than 1.5greater than 5.3

Plateau reached by 30 minutes, well before the 60-minute process hold; kinetics support the claim.

Section 4 (cumulative, illustrative):

VirusLow-pH LRVAEX LRVFiltration LRVCumulative
X-MuLVgreater than 5.3greater than 4.5greater than 4.2greater than 14.0

Section 5: cumulative clearance of X-MuLV (greater than 14 log10) exceeds the estimated retrovirus-like particle burden of the unprocessed bulk by a wide margin, consistent with ICH Q5A(R2) expectations for the relevant virus in a rodent cell line.

Common inspection findings this worksheet prevents

  • LRV computed from titer alone, ignoring volume, which silently inflates or deflates the true total-virus reduction.
  • A below-detection result presented as an exact LRV number instead of a bounded “greater than” value.
  • Non-orthogonal steps summed without a documented mechanism justification.
  • A safety margin asserted without stating the estimated viral burden it is being compared against.

How to adapt this worksheet

  1. Populate Section 1 for every studied step from the contract lab’s raw data report.
  2. Complete Section 2 for any inactivation (time-dependent) step; skip it for pure removal steps.
  3. Work through the orthogonality check in Section 3 before summing anything in Section 4.
  4. State the safety margin in Section 5 against your own estimated viral burden data (e.g., TEM particle counts on unprocessed bulk).
  5. If this worksheet becomes a standing spreadsheet tool, validate it and control its formulas per change control.
Use madhadi.com as an app Full screen, works offline, one tap from your home screen.